Joseph C. Papa, President and CEO of Emergent BioSolutions Inc. ($EBS), made one open market purchase of company shares in the past year, totaling $350,000, with the most recent on May 13, 2025. This ranks 1,063rd among nearly 5,000 insiders, below the average of $1.5 million over 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Candel Therapeutics, Inc. | $CADL | PAPA JOSEPH C | Not found | A | Stock Option (Right to Buy) | 2795 | $4.11 | 2,795.0000 | 55,018,457 | 9999.99% | 0.01% |
| March 5, 2026 | Emergent BioSolutions Inc. | $EBS | PAPA JOSEPH C | President and CEO | F | Common Stock | 37055 | $8.44 | 305,445.0000 | 56,700,000 | 10.82% | 0.07% |
| March 3, 2026 | Emergent BioSolutions Inc. | $EBS | PAPA JOSEPH C | President and CEO | A | Employee Stock Option (Right to buy) | 252194 | $0.00 | 1,784,694.0000 | 56,700,000 | 16.46% | 0.44% |
| July 11, 2025 | Milestone Pharmaceuticals Inc. | $MIST | PAPA JOSEPH C | Not found | A | Common Shares | 100000 | $0.00 | 100,000.0000 | 53,464,273 | 9999.99% | 0.19% |
| July 11, 2025 | Milestone Pharmaceuticals Inc. | $MIST | PAPA JOSEPH C | Not found | A | Series B Common Warrants (right to buy) | 100000 | $0.00 | 100,000.0000 | 53,464,273 | 9999.99% | 0.19% |
| July 11, 2025 | Milestone Pharmaceuticals Inc. | $MIST | PAPA JOSEPH C | Not found | A | Series A Common Warrants (right to buy) | 100000 | $0.00 | 100,000.0000 | 53,464,273 | 9999.99% | 0.19% |
| June 25, 2025 | Candel Therapeutics, Inc. | $CADL | PAPA JOSEPH C | Not found | A | Common Stock | 64239 | $4.67 | 102,271.0000 | 46,933,088 | 168.91% | 0.14% |
| June 17, 2025 | Candel Therapeutics, Inc. | $CADL | PAPA JOSEPH C | Not found | A | Stock Option (Right to Buy) | 14240 | $0.00 | 14,240.0000 | 46,933,088 | 9999.99% | 0.03% |
| June 10, 2025 | Milestone Pharmaceuticals Inc. | $MIST | PAPA JOSEPH C | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 53,464,273 | 9999.99% | 0.07% |
| May 13, 2025 | Emergent BioSolutions Inc. | $EBS | PAPA JOSEPH C | President and CEO | P | Common Stock | 60000 | $5.83 | 342,500.0000 | 53,000,000 | 21.24% | 0.11% |
| March 12, 2025 | Emergent BioSolutions Inc. | $EBS | PAPA JOSEPH C | President and CEO | A | Employee Stock Options (Right to Buy) | 250000 | $0.00 | 1,282,500.0000 | 53,000,000 | 24.21% | 0.47% |
| March 12, 2025 | Emergent BioSolutions Inc. | $EBS | PAPA JOSEPH C | President and CEO | A | Employee Stock Options (Right to Buy) | 250000 | $0.00 | 1,532,500.0000 | 53,000,000 | 19.49% | 0.47% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | PAPA JOSEPH C | President and CEO | A | Common Stock | 282500 | $0.00 | 282,500.0000 | 53,000,000 | 9999.99% | 0.53% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | PAPA JOSEPH C | President and CEO | A | Employee Stock Options (Right to Buy) | 282500 | $0.00 | 1,032,500.0000 | 53,000,000 | 37.67% | 0.53% |
| Sept. 3, 2024 | Milestone Pharmaceuticals Inc. | $MIST | PAPA JOSEPH C | Not found | A | Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 53,269,565 | 9999.99% | 0.15% |
| June 26, 2024 | Candel Therapeutics, Inc. | $CADL | PAPA JOSEPH C | Not found | A | Stock Option (Right to Buy) | 14240 | $0.00 | 14,240.0000 | 29,213,627 | 9999.99% | 0.05% |
| March 13, 2024 | Emergent BioSolutions Inc. | $EBS | PAPA JOSEPH C | President and CEO | A | Employee Stock Options (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 51,200,000 | 9999.99% | 1.46% |